Jianqiang Zhang

Iowa State University - United States Author

Education and Certifications

Doctorate (2005) in Veterinary Science (Molecular Virology), University of Kentucky, Lexington, KY

Master's Degree (1999) in Molecular Virology, Chinese Academy of Preventive Medicine, Institute of Virology, Beijing, China

Bachelor of Medicine (1996), Peking Medical University, School of Public Health, Beijing, China

Research Focus and Interests

Development and validation of diagnostic tests for viruses of veterinary importance

Genetic classification, pathogenicity, and cross-protection of PRRSV

Pathogenesis, immune responses, and vaccine development against porcine enteric coronaviruses

Disinfectants and antivirals against various viruses

Honors and Awards

International Service Award, College of Veterinary Medicine, Iowa State University (2021)

MorrisTONE Faculty Fellowship (2020–2021)

Emerging Leaders Academy, Iowa State University (2019–2020)

Best Full Manuscript Award, JVDI (2018)

Zoetis Award for Excellence in Veterinary Research (2016)

Early Achievement in Research Award, Iowa State University (2016)

Early Achievement in Research Award, College of Veterinary Medicine, ISU (2015)

Updated CV 20-May-2025

Jianqiang Zhang 8 Followers 2 Articles

Articles 2

Home

Figure 1: Representation of a recombination event generating a new virus. The region before and after the points where the two lines cross denote the portion of genomes received from the two parental viruses. Genome regions are shown at the top.

HealthArticle

The implications of the PRRSV recombination dilemma

PRRS control measures also reduce the opportunities for different wild-type viruses to recombine and create more aggressive strains.

4 Likecomment

shareMy favorites

Home

Figure 1: Schematic representation of a PRRSV whole genome (GenBank U87392) and the target regions for different diagnostic assays. In the United States, RT-PCR assays to detect modified live virus (MLV) vaccine-like viruses target the nsp2 region, and CLAMP sequencing to block amplification of MLV vaccine viruses during Sanger sequencing targets the ORF5 gene.

HealthArticle

PRRS Molecular diagnostics: when sequencing only 4% is not enough

Genetic mutation and evolution of PRRSV can occur across all genes. Unlike ORF5, which only represents about 4% of the PRRSV genome, NGS can recover a whole PRRSV genome to be used in epidemiological investigations.

1 Like1 Comments

shareMy favorites

02-Jun-2025sonu-kumar_1hack

Jianqiang Zhang

The implications of the PRRSV recombination dilemma

PRRS Molecular diagnostics: when sequencing only 4% is not enough

Zhou Lydia

Mary Wang

Vietstock Expo & Forum EN

WelFarmers

Jyga Technologies